Spots Global Cancer Trial Database for Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure
Official Title: Interest of Morphometric Analysis of Sputum Cytology for Lung Cancer Screening in Workers Highly Exposed to Asbestos - Exploratory Analysis of Biomarkers Predictive for Lung Cancer
Study ID: NCT01687647
Conditions
Study Description
Brief Summary: Workers exposed to asbestos are at high risk of lung cancer. Medical follow-up of this population relies on repeated CT-scans which are more accurate for detection of peripheral lesions, and expose to X-rays and to risk of false-positives. Analysis of sputum using automate cytometry may be of interest in this population, alone or in combination with CT-scan. An ancillary study will evaluate the interest of blood predictive biomarkers.
Detailed Description:
Eligibility
Minimum Age: 56 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Caen University Hospital, Caen, , France
Le Havre Hospital, Le Havre, , France
Rouen University Hospital, Rouen, , France
Contact Details
Name: Lydia GUITTET, MD,PhD
Affiliation: Caen University Hospital, INSERM
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
